Extent of demyelination is decreased following NgR knock down. by Fereshteh Pourabdolhossein (624998)

2-APB decreased the cytokine secretions in human DC. by Romain Félix (586765)

IL-1Ra expressed by MSCs decreased Th17 differentiation. by Kijun Lee (4888660)

DCD is strikingly decreased in HS lesions. by Margaret Coates (6058580)

“…Co-staining was performed with K77 (green), which is a marker of eccrine sweat glands. Scale bar is 100μm. (C) Immunofluorescence for DCD (red) and K77 (green) at 4X showing decreased number of eccrine sweat glands in HS lesional skin. …”

(R+S) and (R)-albuterol decrease NF-κB activity by Marcela A Ferrada (41716)

“…After transfection, (R)-albuterol (R), (S)-albuterol (S), or racemic albuterol (R+ S) were added to cells pre-activated with (ConA, 5 μg/ml) and (PMA, 100 ng/ml) (CP) and then treated with (R)-, (S)-, or (R+S)-albuterol (Fig. 6). …”

h-GAAP Decreases Cell Susceptibility to Extrinsic Apoptosis Pathways by Caroline Gubser (24818)

2-APB decreased the expression of maturation markers in human DC. by Romain Félix (586765)

(R)-albuterol decreases cytokine protein levels in activated T cells by Marcela A Ferrada (41716)

“…</p><p></p> (R)-albuterol, (S)-albuterol or racemic albuterol (R + S) at a dose (10M) were added to T (EL-4) cells pre-activated with mitogens Concanavalin A (Con A, 5 μg/ml) and phorbol myristate acetate (PMA, 100 ng/ml) (CP). …”

(R)-albuterol decreases cytokine levels in activated murine splenocytes by Marcela A Ferrada (41716)

“…</p><p></p> (R)-albuterol (R), (S)-albuterol (S) or racemic albuterol (R + S) at a dose (10M) were added to murine splenocytes pre-activated with mitogens Concanavalin A (Con A, 5 μg/ml) and phorbol myristate acetate (PMA, 100 ng/ml) (CP), (Fig 3 A, B). …”

Decreased osteoclast formation by LDH-A or LDH-B depletion. by Heejin Ahn (3173670)

Cilostazol decreases OC formation and bone resorption induced by RANKL. by Ke Ke (583325)

Monotonically decreasing gene expression in MX-treated TA100 by William O Ward (39946)

Ketamine decreases the ATP level and neurotransmitter reuptake activity in cultured iPSC-derived neurons. by Hiroyuki Ito (339050)

“…In the 6-h treatment, the ATP level significantly decreased to 91% with 100 μM ketamine, and to 66% with 500 μM ketamine, compared with untreated controls. …”

The monoterpene 1,8-cineole decreased parasitemia levels in vitro. by Edgleyson C. dos Santos (12536575)

Subjects:

Knockdown of NG2 by siRNA results in decreased viability and a reduction in PARP levels. by Frank Maus (792209)

Mean GC in medium before adding spheroids, mean 10 min time-averaged GC for the 100 and 75 <i>μ</i>L incubations, mean GC at 4 hours (for 100 <i>μ</i>L), mean GC at 19 hours (for 7... by Hamidreza Arjmandi (19657263)

Association of chemotherapy cycles and nausea and vomiting with the decrease of post-treatment vitamin D concentration (n = 136). by Herindita Puspitaningtyas (11618232)

LPS dose-dependently decreases T cell proliferative response to OKT3. by Fanny Poujol (834338)

(R)-albuterol decreases cytokine mRNA levels in activated T cells by Marcela A Ferrada (41716)

“…</p><p></p> (R)-albuterol, (S)-albuterol or racemic albuterol (R + S) at a dose (10M) were added to T (EL-4) cells pre-activated with mitogens Concanavalin A (Con A, 5 μg/ml) and phorbol myristate acetate (PMA, 100 ng/ml) (CP). …”

IFNγ decreases cell proliferation of NPCs via p21. by Johanna Mäkelä (223358)

“…(<b>G</b>) p53 gene deleted mouse embryonic fibroblasts were treated with 10–100 ng/ml IFNγ for 2 days and cell viability determined as described in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0011091#s4" target="_blank">Methods</a>.…”